Skip to main content
DHR
NYSE Industrial Applications And Services

Danaher Reports Strong Q1 Results, Raises Full-Year EPS Guidance Amidst Strategic Acquisition

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$189
Mkt Cap
$138.355B
52W Low
$180.03
52W High
$242.8
52W Position info
5.0% above low
Off High info
22% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

DHR is trading near its 52-week low of $180.03 (5.0% above the low).

Summary

Danaher reported strong Q1 2026 adjusted EPS growth and revenue increase, while raising its full-year adjusted EPS guidance and highlighting robust cash flow and strategic acquisition plans.


Key Events · Earnings and Guidance · DHR

  • Strong Q1 Adjusted EPS Growth

    Non-GAAP adjusted diluted net earnings per common share grew 9.5% to $2.06 for the first quarter of 2026.

  • Revenue Increase

    Revenues increased 3.5% year-over-year to $6.0 billion, with non-GAAP core revenue up 0.5%.

  • Increased Full-Year EPS Guidance

    The company raised its full-year adjusted diluted net earnings per common share guidance to a range of $8.35 to $8.55, up from the previous $8.35 to $8.50.

  • Robust Cash Flow Generation

    Operating cash flow was $1.3 billion and non-GAAP free cash flow was $1.1 billion for the quarter.


Analysis · DHR · Industrial Applications And Services

Danaher Corporation reported solid first-quarter results, with adjusted diluted EPS growing 9.5% to $2.06, surpassing market expectations. Revenues increased 3.5% year-over-year to $6.0 billion, driven by strength in Bioprocessing and better-than-expected performance in Life Sciences. The company also demonstrated robust operating and free cash flow generation. Significantly, Danaher raised its full-year adjusted diluted net earnings per common share guidance to a range of $8.35 to $8.55, up from the previous $8.35 to $8.50. This positive financial update, coupled with the reiteration of its intention to acquire Masimo Corporation, provides a constructive signal, especially as the stock is currently trading near its 52-week low.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, DHR was trading at $189.00 on NYSE in the Industrial Applications And Services sector, with a market capitalization of approximately $138.4B. The 52-week trading range was $180.03 to $242.80. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DHR - Latest Insights

DHR
Nov 02, 2026, 6:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $237.50
Real-time Price: $227.53 info
Change: -$9.97 (-4%) info
Market Cap: $160.095B info
DHR
Oct 21, 2026, 11:24 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $230.83
Real-time Price: $227.53 info
Change: -$3.30 (-1%) info
Market Cap: $160.095B info
DHR
Oct 21, 2026, 6:00 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $221.00
Real-time Price: $227.53 info
Change: +$6.53 (+3%) info
Market Cap: $160.095B info
DHR
Oct 20, 2026, 5:43 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $221.20
Real-time Price: $227.53 info
Change: +$6.33 (+3%) info
Market Cap: $160.095B info
DHR
Oct 20, 2026, 5:40 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $221.20
Real-time Price: $227.53 info
Change: +$6.33 (+3%) info
Market Cap: $160.095B info